| Literature DB >> 17335944 |
Jue-Hee Lee1, Ju Young Lee, Ji Hye Park, Hye Sil Jung, Ju Sun Kim, Sam Sik Kang, Yeong Shik Kim, Yongmoon Han.
Abstract
In the present study, we investigated immunomodulatory effect of daucosterol, a beta-sitosterol glycoside, against disseminated candidiasis caused by Candida albicans. Results showed that direct interaction of daucosterol with C. albicans yeast cells resulted in no growth-inhibition by in vitro susceptibility analysis. In contrast, mice given daucosterol (DS) intraperitoneally before intravenous challenge with live C. albicans yeast cells survived longer than DS-untreated control mice against disseminated candidiasis (P<0.05). By assessment of the fungal CFU in kidneys, DS-treated mice before the challenge developed about 81% fewer kidney CFU than untreated controls. This protection was removable by pretreatment of mice with anti-CD4+ antibody before the DS-treatment and challenge with the yeast. However, the protection was transferable by the CD4+ T cells from DS-treated mice not infected with the yeast. ELISA analysis revealed there were predominant production of IFNgamma and IL-2 cytokines as compared to IL-4, and IL-10 productions in DS-treated mice. By treatment of DS-given mice with anti-mouse IFNgamma, the protection was also abolished. Our studies show that DS protects mice against disseminated candidiasis by the CD4+ Th1 immune response.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17335944 DOI: 10.1016/j.vaccine.2007.01.108
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641